From Name:
From Email:
To Name:
To Email:

Optional Message:


How A Drug Company Under Pressure For High Prices Ratchets Up Political Activity

from Kaiser Health News

Business looked challenging for Novo Nordisk at the end of 2016. As pressure mounted over the pharma giant's soaring insulin prices, investors drove its stock down by a third on fears that policymakers would take action, limit prices and hurt profits. Then things got worse. A Massachusetts law firm sued the company and two other pharma firms on behalf of patients, claiming that high insulin prices of hundreds of dollars a month forced diabetics to starve themselves to minimize their blood sugar while skimping on doses. more


Powered by MultiBriefs
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063